dc.date.accessioned | 2024-03-01T17:40:03Z | |
dc.date.available | 2024-03-01T17:40:03Z | |
dc.date.created | 2023-10-25T13:25:20Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Meneses Echavez, Jose Francisco Bidonde Torre, Maria Julia Montesinos-Guevara, Camila Amer, Yasser S. Loaiza-Betancur, Andres Felipe Tellez Tinjaca, Luis Andres Fraile Navarro, David Poklepović Peričić, Tina Tokalić, Ružica Bala, Malgorzata M. Storman, Dawid Swierz, Mateusz Zając, Joanna Flórez, Ivan D. Schünemann, Holger Flottorp, Signe Agnes Alonso-Coello, Pablo . Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations. Journal of Clinical Epidemiology. 2023, 162, 38-46 | |
dc.identifier.uri | http://hdl.handle.net/10852/108844 | |
dc.description.abstract | Background and Objectives
To determine whether the use of Evidence to Decision (EtD) frameworks is associated to higher quality of both guidelines and individual recommendations.
Methods
We identified guidelines recently published by international organizations that have methodological guidance documents for their development. Pairs of researchers independently extracted information on the use of these frameworks, appraised the quality of the guidelines using the Appraisal of Guidelines, Research and Evaluation II Instrument (AGREE-II), and assessed the clinical credibility and implementability of the recommendations with the Appraisal of Guidelines for REsearch & Evaluation Recommendations Excellence (AGREE-REX) tool. We conducted both descriptive and inferential analyses.
Results
We included 66 guidelines from 17 different countries, published in the last 5 years. Thirty guidelines (45%) used an EtD framework to formulate their recommendations. Compared to those that did not use a framework, those using an EtD framework scored higher in all domains of both AGREE-II and AGREE-REX (P < 0.05). Quality scores did not differ between the use of the The Grading of Recommendations Assessment, Development and Evaluation–EtD framework (17 guidelines) or another EtD framework (13 guidelines) (P > 0.05).
Conclusion
The use of EtD frameworks is associated with guidelines of better quality, and more credible and transparent recommendations. Endorsement of EtD frameworks by guideline developing organizations will likely increase the quality of their guidelines. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations | |
dc.title.alternative | ENEngelskEnglishUsing evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations | |
dc.type | Journal article | |
dc.creator.author | Meneses Echavez, Jose Francisco | |
dc.creator.author | Bidonde Torre, Maria Julia | |
dc.creator.author | Montesinos-Guevara, Camila | |
dc.creator.author | Amer, Yasser S. | |
dc.creator.author | Loaiza-Betancur, Andres Felipe | |
dc.creator.author | Tellez Tinjaca, Luis Andres | |
dc.creator.author | Fraile Navarro, David | |
dc.creator.author | Poklepović Peričić, Tina | |
dc.creator.author | Tokalić, Ružica | |
dc.creator.author | Bala, Malgorzata M. | |
dc.creator.author | Storman, Dawid | |
dc.creator.author | Swierz, Mateusz | |
dc.creator.author | Zając, Joanna | |
dc.creator.author | Flórez, Ivan D. | |
dc.creator.author | Schünemann, Holger | |
dc.creator.author | Flottorp, Signe Agnes | |
dc.creator.author | Alonso-Coello, Pablo | |
cristin.unitcode | 185,52,15,0 | |
cristin.unitname | Avdeling for allmennmedisin | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |
dc.identifier.cristin | 2188389 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Clinical Epidemiology&rft.volume=162&rft.spage=38&rft.date=2023 | |
dc.identifier.jtitle | Journal of Clinical Epidemiology | |
dc.identifier.volume | 162 | |
dc.identifier.startpage | 38 | |
dc.identifier.endpage | 46 | |
dc.identifier.doi | https://doi.org/10.1016/j.jclinepi.2023.07.013 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 0895-4356 | |
dc.type.version | PublishedVersion | |